Cargando…

Regulation of serine protease inhibitor Kazal type-5 (SPINK5) gene expression in the keratinocytes

OBJECTIVES: Serine protease inhibitor Kazal type-5 (SPINK5) plays a crucial role in deciding the timing of desquamation of the skin. Its gene expression is limited at the very surface of the stratum granulosum (SG), whereas expression of kallikreins (KLKs) encoding proteases is usually found through...

Descripción completa

Detalles Bibliográficos
Autores principales:	Le, Ngoc Anh, Katsuyama, Midori, Demura, Masashi, Tanii, Hideji, Katsuyama, Hironobu, Saijoh, Kiyofumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Japan 2014
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4085257/ https://www.ncbi.nlm.nih.gov/pubmed/24894987 http://dx.doi.org/10.1007/s12199-014-0393-7

Ejemplares similares

Association between posttraumatic stress disorder (PTSD) severity and ego structure of the Nanai people
por: Ota, Yoko, et al.
Publicado: (2017)

Serine protease inhibitor Kazal type 1 (SPINK1) drives proliferation and anoikis resistance in a subset of ovarian cancers
por: Mehner, Christine, et al.
Publicado: (2015)

Anti-Inflammatory and Antioxidant Effects of Repeated Exposure to Cruciferous Allyl Nitrile in Sensitizer-Induced Ear Edema in Mice
por: Tanii, Hideji, et al.
Publicado: (2016)

The impact of physiological stress conditions on protein structure and trypsin inhibition of serine protease inhibitor Kazal type 1 (SPINK1) and its N34S variant
por: Buchholz, Ina, et al.
Publicado: (2020)

The Prevalence of Cationic Trypsinogen (PRSS1) and Serine Protease Inhibitor, Kazal Type 1 (SPINK1) Gene Mutations in Polish Patients with Alcoholic and Idiopathic Chronic Pancreatitis
por: Gasiorowska, Anita, et al.
Publicado: (2010)

Tazarotene-Induced Gene 1 (TIG1) Interacts with Serine Protease Inhibitor Kazal-Type 2 (SPINK2) to Inhibit Cellular Invasion of Testicular Carcinoma Cells
por: Shyu, Rong-Yaun, et al.
Publicado: (2019)

Genetic polymorphisms in serine protease inhibitor Kazal-type 5 and risk of atopic dermatitis: A meta-analysis
por: Li, Yunling, et al.
Publicado: (2020)

Serine Protease Inhibitor Kazal Type 1 (SPINK1) c.194+2T > C Mutation May Predict Long-term Outcome of Endoscopic Treatments in Idiopathic Chronic Pancreatitis
por: Sun, Chang, et al.
Publicado: (2015)

Generation and Analysis of Serine Protease Inhibitor Kazal Type 3-Cre Driver Mice
por: Sakata, Kazuya, et al.
Publicado: (2014)

MAPK inhibitors induce serine peptidase inhibitor Kazal type 1 (SPINK1) secretion in BRAF V600E‐mutant colorectal adenocarcinoma
por: Räsänen, Kati, et al.
Publicado: (2017)

The Role of Serine Peptidase Inhibitor Kazal Type 13 (SPINK13) as a Clinicopathological and Prognostic Biomarker in Patients with Clear Cell Renal Cell Carcinoma
por: Xu, Wen-Hao, et al.
Publicado: (2019)

Serine protease inhibitor Kazal type 1 (SPINK1) promotes proliferation, migration, invasion and radiation resistance in rectal cancer patients receiving concurrent chemoradiotherapy: a potential target for precision medicine
por: Chen, Yi-Ting, et al.
Publicado: (2022)

Temporary serine protease inhibition and the role of SPINK2 in human bone marrow
por: Barresi, Vincenza, et al.
Publicado: (2023)

SPINK6 inhibits human airway serine proteases and restricts influenza virus activation
por: Wang, Dong, et al.
Publicado: (2021)

Kazal-type serine proteinase inhibitors in the midgut of Phlebotomus papatasi
por: Sigle, Leah Theresa, et al.
Publicado: (2013)

A Kazal-Type Serine Protease Inhibitor from the Defense Gland Secretion of the Subterranean Termite Coptotermes formosanus Shiraki
por: Negulescu, Horia, et al.
Publicado: (2015)

Liver Cancer–Specific Serine Protease Inhibitor Kazal Is a Potentially Novel Biomarker for the Early Detection of Hepatocellular Carcinoma
por: Lu, Felix, et al.
Publicado: (2020)

Molecular Cloning and Functional Studies of Two Kazal-Type Serine Protease Inhibitors Specifically Expressed by Nasonia vitripennis Venom Apparatus
por: Qian, Cen, et al.
Publicado: (2015)

Serine protease inhibitor kazal-type 6 inhibits tumorigenesis of human hepatocellular carcinoma cells via its extracellular action
por: Ge, Kuikui, et al.
Publicado: (2016)

A two disulfide bridge Kazal domain from Phytophthora exhibits stable inhibitory activity against serine proteases of the subtilisin family
por: Tian, Miaoying, et al.
Publicado: (2005)

Hepatitis B Virus X Protein-Induced Serine Protease Inhibitor Kazal Type 1 Is Associated with the Progression of HBV-Related Diseases
por: Zhu, Chengliang, et al.
Publicado: (2019)

Structural Basis for Dual-Inhibition Mechanism of a Non-Classical Kazal-Type Serine Protease Inhibitor from Horseshoe Crab in Complex with Subtilisin
por: Shenoy, Rajesh T., et al.
Publicado: (2011)

High Prevalence of Serine Protease Inhibitor Kazal Type 1 Gene Variations Detected by Whole Gene Sequencing in Patients with Fibrocalculous Pancreatic Diabetes
por: Kolly, Anish, et al.
Publicado: (2017)

A Hypothesized Mechanism for Chronic Pancreatitis Caused by the N34S Mutation of Serine Protease Inhibitor Kazal-Type 1 Based on Conformational Studies
por: Kulke, Martin, et al.
Publicado: (2021)

Novel Kazal-type proteinase inhibitors from the skin secretion of the Splendid leaf frog, Cruziohyla calcarifer
por: Proaño-Bolaños, Carolina, et al.
Publicado: (2017)

Liver Cancer-Specific Isoform of Serine Protease Inhibitor Kazal for the Detection of Hepatocellular Carcinoma: Results from a Pilot Study in Patients with Dysmetabolic Liver Disease
por: Caviglia, Gian Paolo, et al.
Publicado: (2022)

Serine Protease Inhibitor Kazal Type 1, A Potential Biomarker for the Early Detection, Targeting, and Prediction of Response to Immune Checkpoint Blockade Therapies in Hepatocellular Carcinoma
por: Jia, Jianlong, et al.
Publicado: (2022)

Transcriptome analysis of the effect of a novel human serine protease inhibitor SPINK13 on gene expression in MHCC97-H cells
por: Wei, Ling, et al.
Publicado: (2021)

Investigation on substrate specificity and catalytic activity of serine protease neuropsin
por: Lintuluoto, Masami, et al.
Publicado: (2022)

Identification of Lympho-Epithelial Kazal-Type Inhibitor 2 in Human Skin as a Kallikrein-Related Peptidase 5-Specific Protease Inhibitor
por: Meyer-Hoffert, Ulf, et al.
Publicado: (2009)

Improving the catalytic activity of a detergent‐compatible serine protease by rational design
por: Wang, Xiao, et al.
Publicado: (2023)

Effects of pseudoexperience on the understanding of hemiplegic movements in physical therapists: An fMRI study
por: Watanabe, Rui, et al.
Publicado: (2019)

Expression of trans-membrane serine protease 3 (TMPRSS3) in the human organ of Corti
por: Liu, Wei, et al.
Publicado: (2018)

Willingness to Receive COVID-19 Vaccination in Japan
por: Yoda, Takeshi, et al.
Publicado: (2021)

Analysis of antibody-negative medical students after hepatitis B vaccination in Japan
por: Yoda, Takeshi, et al.
Publicado: (2020)

Allyl nitrile: Toxicity and health effects
por: Tanii, Hideji
Publicado: (2017)

Differential expression of a novel serine protease homologue in squamous cell carcinoma of the head and neck
por: Lang, J C, et al.
Publicado: (2001)

Role of Intrapancreatic SPINK1/Spink3 Expression in the Development of Pancreatitis
por: Ohmuraya, Masaki, et al.
Publicado: (2012)

Kallikrein 5 Inhibition by the Lympho-Epithelial Kazal-Type Related Inhibitor Hinders Matriptase-Dependent Carcinogenesis
por: da Silva, Elaine Zayas Marcelino, et al.
Publicado: (2021)

Compound K improves skin barrier function by increasing SPINK5 expression
por: Park, No-June, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lu823gms8cbla73vgk6s4q3nem